O'Reilly K J
J Hyg (Lond). 1971 Dec;69(4):627-35. doi: 10.1017/s0022172400021902.
In the course of developing a living attenuated feline infectious enteritis (panleucopaenia) vaccine, it was found that respiratory disease-infected cats newly inoculated with this vaccine spread vaccine virus to respiratory disease-infected in-contact controls. These in-contact controls were able to infect other cats with which they were placed in contact so that after five natural transmissions in this way and two oral administrations and subsequent re-isolations, reversion to virulence became evident. It is clear that before general release of a new living feline infectious enteritis vaccine, there must be satisfactory evidence that concurrent infection will not affect the safety of the modified antigen.In cats infected with feline infectious enteritis there appears to be a short period, coinciding with the onset of leucopaenia, during which they are highly infectious. It seems possible that some infected animals may become immune carriers because virus has been recovered from the small intestine of two of four cats with significant antibody titres 22-24 days after exposure to infection.
在研发减毒活猫传染性肠炎(泛白细胞减少症)疫苗的过程中,发现新接种该疫苗的呼吸道疾病感染猫将疫苗病毒传播给了呼吸道疾病感染的接触对照组。这些接触对照组能够将病毒传染给与其接触的其他猫,以至于通过这种方式经过五次自然传播、两次口服接种及随后的再次分离后,毒力返祖现象变得明显。显然,在新的减毒活猫传染性肠炎疫苗普遍投放市场之前,必须有充分的证据表明并发感染不会影响改良抗原的安全性。在感染猫传染性肠炎的猫中,似乎有一段短暂时期,与白细胞减少症的发作同时出现,在此期间它们具有高度传染性。有可能一些感染动物会成为免疫携带者,因为在暴露于感染后22 - 24天,在四只抗体滴度显著的猫中的两只的小肠中检测到了病毒。